0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Post-Traumatic Stress Disorder (PTSD) Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-2L2344
Home | Market Reports | Health | Mental Health
Global Post Traumatic Stress Disorder PTSD Market Insights and Forecast to 2028

Global Post-Traumatic Stress Disorder (PTSD) Market Insights and Forecast to 2028

Code: QYRE-Auto-2L2344
Report
May 2022
127 Pages
QYResearch
Region: Global, North America, Japan, Europe, Central & South America,
Description
Table of Content
Tables & Figures
Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.
Market Analysis and Insights: Global Post-Traumatic Stress Disorder (PTSD) Market

The global Post-Traumatic Stress Disorder (PTSD) market size is projected to reach US$ 3135.3 million by 2028, from US$ 2410.2 million in 2021, at a CAGR of 3.8% during 2022-2028.

Fully considering the economic change by this health crisis, Cognitive Therapy accounting for % of the Post-Traumatic Stress Disorder (PTSD) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Children segment is altered to an % CAGR throughout this forecast period.
China Post-Traumatic Stress Disorder (PTSD) market size is valued at US$ million in 2021, while the North America and Europe Post-Traumatic Stress Disorder (PTSD) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Post-Traumatic Stress Disorder (PTSD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post-Traumatic Stress Disorder (PTSD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post-Traumatic Stress Disorder (PTSD) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post-Traumatic Stress Disorder (PTSD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post-Traumatic Stress Disorder (PTSD) market.
Global Post-Traumatic Stress Disorder (PTSD) Scope and Market Size
Post-Traumatic Stress Disorder (PTSD) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder (PTSD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Cognitive Therapy
Exposure Therapy
Eye Movement Desensitization And Reprocessing (EMDR)
Antidepressants
Anti-Anxiety Medications
Prazosin

Segment by Application

Children
Adult

BY COMPANY

GlaxoSmithKline (UK)
Pfizer (US)
Eli Lilly and Company (US)
Lundbeck A/S (Denmark)
Azevan Pharmaceuticals (US)
Marinus Pharmaceuticals, Inc. (US)
Tonix Pharmaceuticals Holding Corp. (US)
Bionomics (Australia)
Greenstone LLC (US)
Mylan NV (US)
Otsuka Pharmaceutical (Japan)
Prometheon Pharma (USA)
Ligand Pharma (USA)
Valenta Pharm (Russia)
Lycera Corp (US)
Archimedes (UK)
GMP Endotherapeutics (USA)
Nuvo Pharmaceuticals (Canada)
Beijing Wansheng Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Jianfeng Pharmaceutical

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cognitive Therapy
1.2.3 Exposure Therapy
1.2.4 Eye Movement Desensitization And Reprocessing (EMDR)
1.2.5 Antidepressants
1.2.6 Anti-Anxiety Medications
1.2.7 Prazosin
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Perspective (2017-2028)
2.2 Post-Traumatic Stress Disorder (PTSD) Growth Trends by Region
2.2.1 Post-Traumatic Stress Disorder (PTSD) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Region (2017-2022)
2.2.3 Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2023-2028)
2.3 Post-Traumatic Stress Disorder (PTSD) Market Dynamics
2.3.1 Post-Traumatic Stress Disorder (PTSD) Industry Trends
2.3.2 Post-Traumatic Stress Disorder (PTSD) Market Drivers
2.3.3 Post-Traumatic Stress Disorder (PTSD) Market Challenges
2.3.4 Post-Traumatic Stress Disorder (PTSD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue (2017-2022)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Players (2017-2022)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Revenue
3.4 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Revenue in 2021
3.5 Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Type (2017-2022)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2023-2028)
5 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Application (2017-2022)
5.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
6.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type
6.2.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)
6.2.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)
6.2.3 North America Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)
6.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application
6.3.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)
6.3.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)
6.3.3 North America Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)
6.4 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country
6.4.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
6.4.2 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type
7.2.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)
7.2.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)
7.2.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application
7.3.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)
7.3.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)
7.3.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)
7.4 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country
7.4.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
7.4.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
8.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type
8.2.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)
8.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application
8.3.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)
8.4 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region
8.4.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
9.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type
9.2.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)
9.2.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)
9.2.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)
9.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application
9.3.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)
9.3.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)
9.3.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)
9.4 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country
9.4.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
9.4.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size (2017-2028)
10.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type
10.2.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Type (2017-2028)
10.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application
10.3.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Application (2017-2028)
10.4 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country
10.4.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline (UK)
11.1.1 GlaxoSmithKline (UK) Company Details
11.1.2 GlaxoSmithKline (UK) Business Overview
11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.1.4 GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.1.5 GlaxoSmithKline (UK) Recent Developments
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Details
11.2.2 Pfizer (US) Business Overview
11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.2.4 Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.2.5 Pfizer (US) Recent Developments
11.3 Eli Lilly and Company (US)
11.3.1 Eli Lilly and Company (US) Company Details
11.3.2 Eli Lilly and Company (US) Business Overview
11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.3.4 Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.3.5 Eli Lilly and Company (US) Recent Developments
11.4 Lundbeck A/S (Denmark)
11.4.1 Lundbeck A/S (Denmark) Company Details
11.4.2 Lundbeck A/S (Denmark) Business Overview
11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Introduction
11.4.4 Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.4.5 Lundbeck A/S (Denmark) Recent Developments
11.5 Azevan Pharmaceuticals (US)
11.5.1 Azevan Pharmaceuticals (US) Company Details
11.5.2 Azevan Pharmaceuticals (US) Business Overview
11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.5.4 Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.5.5 Azevan Pharmaceuticals (US) Recent Developments
11.6 Marinus Pharmaceuticals, Inc. (US)
11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Details
11.6.2 Marinus Pharmaceuticals, Inc. (US) Business Overview
11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.6.4 Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.6.5 Marinus Pharmaceuticals, Inc. (US) Recent Developments
11.7 Tonix Pharmaceuticals Holding Corp. (US)
11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Details
11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Business Overview
11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Recent Developments
11.8 Bionomics (Australia)
11.8.1 Bionomics (Australia) Company Details
11.8.2 Bionomics (Australia) Business Overview
11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.8.4 Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.8.5 Bionomics (Australia) Recent Developments
11.9 Greenstone LLC (US)
11.9.1 Greenstone LLC (US) Company Details
11.9.2 Greenstone LLC (US) Business Overview
11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.9.4 Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.9.5 Greenstone LLC (US) Recent Developments
11.10 Mylan NV (US)
11.10.1 Mylan NV (US) Company Details
11.10.2 Mylan NV (US) Business Overview
11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.10.4 Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.10.5 Mylan NV (US) Recent Developments
11.11 Otsuka Pharmaceutical (Japan)
11.11.1 Otsuka Pharmaceutical (Japan) Company Details
11.11.2 Otsuka Pharmaceutical (Japan) Business Overview
11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Introduction
11.11.4 Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.11.5 Otsuka Pharmaceutical (Japan) Recent Developments
11.12 Prometheon Pharma (USA)
11.12.1 Prometheon Pharma (USA) Company Details
11.12.2 Prometheon Pharma (USA) Business Overview
11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.12.4 Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.12.5 Prometheon Pharma (USA) Recent Developments
11.13 Ligand Pharma (USA)
11.13.1 Ligand Pharma (USA) Company Details
11.13.2 Ligand Pharma (USA) Business Overview
11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.13.4 Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.13.5 Ligand Pharma (USA) Recent Developments
11.14 Valenta Pharm (Russia)
11.14.1 Valenta Pharm (Russia) Company Details
11.14.2 Valenta Pharm (Russia) Business Overview
11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.14.4 Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.14.5 Valenta Pharm (Russia) Recent Developments
11.15 Lycera Corp (US)
11.15.1 Lycera Corp (US) Company Details
11.15.2 Lycera Corp (US) Business Overview
11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.15.4 Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.15.5 Lycera Corp (US) Recent Developments
11.16 Archimedes (UK)
11.16.1 Archimedes (UK) Company Details
11.16.2 Archimedes (UK) Business Overview
11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.16.4 Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.16.5 Archimedes (UK) Recent Developments
11.17 GMP Endotherapeutics (USA)
11.17.1 GMP Endotherapeutics (USA) Company Details
11.17.2 GMP Endotherapeutics (USA) Business Overview
11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.17.4 GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.17.5 GMP Endotherapeutics (USA) Recent Developments
11.18 Nuvo Pharmaceuticals (Canada)
11.18.1 Nuvo Pharmaceuticals (Canada) Company Details
11.18.2 Nuvo Pharmaceuticals (Canada) Business Overview
11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Introduction
11.18.4 Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.18.5 Nuvo Pharmaceuticals (Canada) Recent Developments
11.19 Beijing Wansheng Pharmaceutical
11.19.1 Beijing Wansheng Pharmaceutical Company Details
11.19.2 Beijing Wansheng Pharmaceutical Business Overview
11.19.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.19.4 Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.19.5 Beijing Wansheng Pharmaceutical Recent Developments
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Company Details
11.20.2 Zhejiang Huahai Pharmaceutical Business Overview
11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.20.4 Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.20.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.21 Zhejiang Jianfeng Pharmaceutical
11.21.1 Zhejiang Jianfeng Pharmaceutical Company Details
11.21.2 Zhejiang Jianfeng Pharmaceutical Business Overview
11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.21.4 Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
11.21.5 Zhejiang Jianfeng Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Cognitive Therapy
    Table 3. Key Players of Exposure Therapy
    Table 4. Key Players of Eye Movement Desensitization And Reprocessing (EMDR)
    Table 5. Key Players of Antidepressants
    Table 6. Key Players of Anti-Anxiety Medications
    Table 7. Key Players of Prazosin
    Table 8. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2017-2022)
    Table 12. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2023-2028)
    Table 14. Post-Traumatic Stress Disorder (PTSD) Market Trends
    Table 15. Post-Traumatic Stress Disorder (PTSD) Market Drivers
    Table 16. Post-Traumatic Stress Disorder (PTSD) Market Challenges
    Table 17. Post-Traumatic Stress Disorder (PTSD) Market Restraints
    Table 18. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Post-Traumatic Stress Disorder (PTSD) Revenue Share by Players (2017-2022)
    Table 20. Global Top Post-Traumatic Stress Disorder (PTSD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2021)
    Table 21. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service
    Table 25. Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2017-2022)
    Table 29. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2023-2028)
    Table 31. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Post-Traumatic Stress Disorder (PTSD) Revenue Share by Application (2017-2022)
    Table 33. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Post-Traumatic Stress Disorder (PTSD) Revenue Share by Application (2023-2028)
    Table 35. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2023-2028) & (US$ Million)
    Table 65. GlaxoSmithKline (UK) Company Details
    Table 66. GlaxoSmithKline (UK) Business Overview
    Table 67. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product
    Table 68. GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 69. GlaxoSmithKline (UK) Recent Developments
    Table 70. Pfizer (US) Company Details
    Table 71. Pfizer (US) Business Overview
    Table 72. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product
    Table 73. Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 74. Pfizer (US) Recent Developments
    Table 75. Eli Lilly and Company (US) Company Details
    Table 76. Eli Lilly and Company (US) Business Overview
    Table 77. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product
    Table 78. Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 79. Eli Lilly and Company (US) Recent Developments
    Table 80. Lundbeck A/S (Denmark) Company Details
    Table 81. Lundbeck A/S (Denmark) Business Overview
    Table 82. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product
    Table 83. Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 84. Lundbeck A/S (Denmark) Recent Developments
    Table 85. Azevan Pharmaceuticals (US) Company Details
    Table 86. Azevan Pharmaceuticals (US) Business Overview
    Table 87. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product
    Table 88. Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 89. Azevan Pharmaceuticals (US) Recent Developments
    Table 90. Marinus Pharmaceuticals, Inc. (US) Company Details
    Table 91. Marinus Pharmaceuticals, Inc. (US) Business Overview
    Table 92. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product
    Table 93. Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 94. Marinus Pharmaceuticals, Inc. (US) Recent Developments
    Table 95. Tonix Pharmaceuticals Holding Corp. (US) Company Details
    Table 96. Tonix Pharmaceuticals Holding Corp. (US) Business Overview
    Table 97. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product
    Table 98. Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 99. Tonix Pharmaceuticals Holding Corp. (US) Recent Developments
    Table 100. Bionomics (Australia) Company Details
    Table 101. Bionomics (Australia) Business Overview
    Table 102. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product
    Table 103. Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 104. Bionomics (Australia) Recent Developments
    Table 105. Greenstone LLC (US) Company Details
    Table 106. Greenstone LLC (US) Business Overview
    Table 107. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product
    Table 108. Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 109. Greenstone LLC (US) Recent Developments
    Table 110. Mylan NV (US) Company Details
    Table 111. Mylan NV (US) Business Overview
    Table 112. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product
    Table 113. Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 114. Mylan NV (US) Recent Developments
    Table 115. Otsuka Pharmaceutical (Japan) Company Details
    Table 116. Otsuka Pharmaceutical (Japan) Business Overview
    Table 117. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product
    Table 118. Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 119. Otsuka Pharmaceutical (Japan) Recent Developments
    Table 120. Prometheon Pharma (USA) Company Details
    Table 121. Prometheon Pharma (USA) Business Overview
    Table 122. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product
    Table 123. Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 124. Prometheon Pharma (USA) Recent Developments
    Table 125. Ligand Pharma (USA) Company Details
    Table 126. Ligand Pharma (USA) Business Overview
    Table 127. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product
    Table 128. Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 129. Ligand Pharma (USA) Recent Developments
    Table 130. Valenta Pharm (Russia) Company Details
    Table 131. Valenta Pharm (Russia) Business Overview
    Table 132. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product
    Table 133. Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 134. Valenta Pharm (Russia) Recent Developments
    Table 135. Lycera Corp (US) Company Details
    Table 136. Lycera Corp (US) Business Overview
    Table 137. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product
    Table 138. Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 139. Lycera Corp (US) Recent Developments
    Table 140. Archimedes (UK) Company Details
    Table 141. Archimedes (UK) Business Overview
    Table 142. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product
    Table 143. Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 144. Archimedes (UK) Recent Developments
    Table 145. GMP Endotherapeutics (USA) Company Details
    Table 146. GMP Endotherapeutics (USA) Business Overview
    Table 147. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product
    Table 148. GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 149. GMP Endotherapeutics (USA) Recent Developments
    Table 150. Nuvo Pharmaceuticals (Canada) Company Details
    Table 151. Nuvo Pharmaceuticals (Canada) Business Overview
    Table 152. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product
    Table 153. Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 154. Nuvo Pharmaceuticals (Canada) Recent Developments
    Table 155. Beijing Wansheng Pharmaceutical Company Details
    Table 156. Beijing Wansheng Pharmaceutical Business Overview
    Table 157. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
    Table 158. Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 159. Beijing Wansheng Pharmaceutical Recent Developments
    Table 160. Zhejiang Huahai Pharmaceutical Company Details
    Table 161. Zhejiang Huahai Pharmaceutical Business Overview
    Table 162. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
    Table 163. Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 164. Zhejiang Huahai Pharmaceutical Recent Developments
    Table 165. Zhejiang Jianfeng Pharmaceutical Company Details
    Table 166. Zhejiang Jianfeng Pharmaceutical Business Overview
    Table 167. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
    Table 168. Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022) & (US$ Million)
    Table 169. Zhejiang Jianfeng Pharmaceutical Recent Developments
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Type: 2021 VS 2028
    Figure 2. Cognitive Therapy Features
    Figure 3. Exposure Therapy Features
    Figure 4. Eye Movement Desensitization And Reprocessing (EMDR) Features
    Figure 5. Antidepressants Features
    Figure 6. Anti-Anxiety Medications Features
    Figure 7. Prazosin Features
    Figure 8. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application: 2021 VS 2028
    Figure 9. Children Case Studies
    Figure 10. Adult Case Studies
    Figure 11. Post-Traumatic Stress Disorder (PTSD) Report Years Considered
    Figure 12. Global Post-Traumatic Stress Disorder (PTSD) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region: 2021 VS 2028
    Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players in 2021
    Figure 16. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue in 2021
    Figure 18. North America Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)
    Figure 20. North America Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)
    Figure 21. North America Post-Traumatic Stress Disorder (PTSD) Market Size Share by Country (2017-2028)
    Figure 22. United States Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Share by Country (2017-2028)
    Figure 28. Germany Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Share by Region (2017-2028)
    Figure 38. China Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Share by Country (2017-2028)
    Figure 48. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Market Size Share by Country (2017-2028)
    Figure 54. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. GlaxoSmithKline (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 58. Pfizer (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 59. Eli Lilly and Company (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 60. Lundbeck A/S (Denmark) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 61. Azevan Pharmaceuticals (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 62. Marinus Pharmaceuticals, Inc. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 63. Tonix Pharmaceuticals Holding Corp. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 64. Bionomics (Australia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 65. Greenstone LLC (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 66. Mylan NV (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 67. Otsuka Pharmaceutical (Japan) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 68. Prometheon Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 69. Ligand Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 70. Valenta Pharm (Russia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 71. Lycera Corp (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 72. Archimedes (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 73. GMP Endotherapeutics (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 74. Nuvo Pharmaceuticals (Canada) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 75. Beijing Wansheng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 76. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 77. Zhejiang Jianfeng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2017-2022)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global Post Traumatic Stress Disorder PTSD Market Insights and Forecast to 2028
Global Post-Traumatic Stress Disorder (PTSD) Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-2L2344
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Quetiapine Market Insights and Forecast to 2028
Global Quetiapine Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-5K7905
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Drugs for Treating Mental Disorders Market Insights and Forecast to 2028
Global Drugs for Treating Mental Disorders Market Insights and Forecast to 2028

Market Analysis and Insights Global Drugs for Treating Mental Disorders MarketThe global Drugs for Treating Mental Disorders market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Tablets accounting for of the Drugs for Treating Mental Disorders global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-26Q10074
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Vortioxetine Market Insights and Forecast to 2028
Global Vortioxetine Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-24S7624
Tue May 03 00:00:00 UTC 2022

Add to Cart